Metraipolis › archive › dc_4b8a482d16e2

Unlocking new therapeutic horizons through integrative bioinformatics and transcriptomics for drug repositioning in breast cancer therapy — Europe PMC PMID:42156642

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42156642
DOI
10.1186/s43046-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-10-08T04:35:13.740Z
SHA-256 of the archived text
186294126e0b236475cb731c47094e031a9efe8c5153e7abe38a9f2bb1dcd1ab
Stable URL of this page
https://metraipolis.com/documento/dc_4b8a482d16e2

How to cite

Unlocking new therapeutic horizons through integrative bioinformatics and transcriptomics for drug repositioning in breast cancer therapy — Europe PMC PMID:42156642 — Europe PMC (en), https://europepmc.org/article/MED/42156642 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4b8a482d16e2 (Metraipolis archive dc_4b8a482d16e2, sha256 186294126e0b236475cb731c47094e031a9efe8c5153e7abe38a9f2bb1dcd1ab)
BibTeX
@misc{dc4b8a482d16e2,
  title = {Unlocking new therapeutic horizons through integrative bioinformatics and transcriptomics for drug repositioning in breast cancer therapy — Europe PMC PMID:42156642},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42156642},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4b8a482d16e2; sha256 186294126e0b236475cb731c47094e031a9efe8c5153e7abe38a9f2bb1dcd1ab},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42156642. Agents can read the archived copy with the MCP tool read_document.